“pembrolizumab-keytruda” Archives

in
Entry Author Date Location
Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better 06/19/20 Raleigh Durham
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
GlaxoSmithKline Keeps Oncology 2.0 Growth Plans on Track 06/12/20 National
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex 01/06/20 New York
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone 09/06/19 National
Merck Data Are Another Step for Immunotherapy in Breast Cancer 07/29/19 New York
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Merck Wins FDA Nod for Combo Therapy in Advanced Kidney Cancer 04/22/19 New York
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Bio Roundup: Dunsire’s Danish, Price Hikes, Rare-Disease Race & More 07/06/18 National
Page 1 of 1